Please enable Javascript

Labmeeting uses lots of Javascript - basically you can't use the site without it. So please enable Javascript in your browser. If your browser does not support Javascript, we recommend Firefox.

Papers authored by Trojan L

Collect these papers and discover other ones on Labmeeting. Learn more.

The role of lymphangiogenesis in lymphatic tumour spread of urological cancers.

+ cite this

+ View Abstract

Bolenz C, Fernández MI, Tilki D, Herrmann E, Heinzelbecker J, Ergün S, Ströbel P, Reich O, Michel MS, and Trojan L

BJU international 104(5):592-7, 2009 Sep - Who cited this? | PubMed ID: 19594740 | Fulltext

Paclitaxel encapsulated in cationic liposomes: A new option for neovascular targeting for the treatment of prostate cancer.

+ cite this

+ View Abstract

Bode C, Trojan L, Weiss C, Kraenzlin B, Michaelis U, Teifel M, Alken P, and Michel MS

Oncology reports 22(2):321-6, 2009 Aug - Who cited this? | PubMed ID: 19578772 | Fulltext

Evaluation framework for a multi-site practice-based interprofessional education intervention.

+ cite this

+ View Abstract

Trojan L, Suter E, Arthur N, and Taylor E

Journal of interprofessional care 23(4):380-9, 2009 Jul - Who cited this? | PubMed ID: 19370447 | Fulltext

The lymphatic system and its specific growth factor vascular endothelial growth factor C in kidney tissue and in renal cell carcinoma.

+ cite this

+ View Abstract

Voss M, Steidler A, Grobholz R, Weiss C, Alken P, Michel MS, and Trojan L

BJU international 104(1):94-9, 2009 Jul - Who cited this? | PubMed ID: 19500329 | Fulltext

In vivo evaluation of intravesical paclitaxel and combined bcl-xL antisense oligodeoxynucleotide treatment for orthotopic urothelial carcinoma.

+ cite this

+ View Abstract

Bolenz C, Weiss C, Wenzel M, Gabriel U, Steidler A, Becker A, Herrmann E, Trojan L, and Michel MS

Journal of cancer research and clinical oncology 135(5):679-86, 2009 May - Who cited this? | PubMed ID: 18941779 | Fulltext

Clinical staging error in prostate cancer: localization and relevance of undetected tumour areas.

+ cite this

+ View Abstract

Bolenz C, Gierth M, Grobholz R, Köpke T, Semjonow A, Weiss C, Alken P, Michel MS, and Trojan L

BJU international 103(9):1184-9, 2009 May - Who cited this? | PubMed ID: 19154463 | Fulltext

Lymphangiogenesis occurs in upper tract urothelial carcinoma and correlates with lymphatic tumour dissemination and poor prognosis.

+ cite this

+ View Abstract

Bolenz C, Fernández MI, Trojan L, Hoffmann K, Herrmann E, Steidler A, Weiss C, Ströbel P, Alken P, and Michel MS

BJU international 103(8):1040-6, 2009 Apr - Who cited this? | PubMed ID: 18990139 | Fulltext

An alternative continence tube for continent urinary reservoirs: evaluation of surgical technique, pressure and continence study in an ex-vivo model.

+ cite this

+ View Abstract

Honeck P, Michel MS, Trojan L, and Alken P

World journal of urology 27(1):131-7, 2009 Feb - Who cited this? | PubMed ID: 18607599 | Fulltext

Joint evolutionary trees: a large-scale method to predict protein interfaces based on sequence sampling.

+ cite this

+ View Abstract

Engelen S, Trojan LA, Sacquin-Mora S, Lavery R, and Carbone A

PLoS computational biology 5(1):e1000267, 2009 Jan - Who cited this? | PubMed ID: 19165315 | Fulltext

[Medical treatment of metastatic renal cell carcinoma after the approval and market entry of multitargeted tyrosine kinase inhibitors in Germany.].

+ cite this

+ View Abstract

Bolenz C, Trojan L, Honeck P, Schöppler G, Herrmann E, Alken P, Michel MS, and Häcker A

Aktuelle Urologie 40(1):31-6, 2009 Jan - Who cited this? | PubMed ID: 19177319 | Fulltext

Complementary therapies for cancer patients: assessing information use and needs.

+ cite this

+ View Abstract

Verhoef MJ, Trojan L, Armitage GD, Carlson L, and Hilsden RJ

Chronic diseases in Canada 29(2):80-8, 2009 - Who cited this? | PubMed ID: 19281693 | Fulltext

Evaluation of cytotoxic effects induced by bcl-2 and bcl-xL antisense-oligodeoxynucleotides in normal urothelium and transitional cell carcinoma.

+ cite this

+ View Abstract

Gabriel U, Bolenz C, Becker A, Schaaf A, Steidler A, Trojan L, Weiss C, and Michel MS

Oncology reports 20(6):1419-23, 2008 Dec - Who cited this? | PubMed ID: 19020723 | Fulltext

Long-term health-related quality-of-life outcomes after permanent prostate brachytherapy.

+ cite this

+ View Abstract

Schafer JW, Welzel G, Trojan L, Eppler N, Harrer K, Michel MS, Alken P, and Wenz F

Onkologie 31(11):599-603, 2008 Nov - Who cited this? | PubMed ID: 19145092 | Fulltext

Cellular uptake and ex vivo urothelial penetration by oligodeoxynucleotides for optimizing treatment of transitional cell carcinoma.

+ cite this

+ View Abstract

Bolenz C, Trojan L, Gabriel U, Honeck P, Wendt-Nordahl G, Schaaf A, Alken P, and Michel MS

Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 30(5):265-73, 2008 Oct - Who cited this? | PubMed ID: 18980158 | Fulltext

Lymphovascular invasion and pathologic tumor stage are significant outcome predictors for patients with upper tract urothelial carcinoma.

+ cite this

+ View Abstract

Bolenz C, Fernández MI, Trojan L, Herrmann E, Becker A, Weiss C, Alken P, Ströbel P, and Michel MS

Urology 72(2):364-9, 2008 Aug - Who cited this? | PubMed ID: 18579189 | Fulltext

Serum vascular endothelial growth factor C level in patients with prostate cancer and benign prostatic hyperplasia.

+ cite this

+ View Abstract

Voss M, Trojan L, Steidler A, Weiss C, Grobholz R, Alken P, and Michel MS

Analytical and quantitative cytology and histology / the International Academy of Cytology [and] American Society of Cytology 30(4):199-202, 2008 Aug - Who cited this? | PubMed ID: 18773737 | Fulltext

Topical Chemotherapy in Human Urothelial Carcinoma Explants: A Novel Translational Tool for Preclinical Evaluation of Experimental Intravesical Therapies.

+ cite this

+ View Abstract

Bolenz C, Ikinger EM, Ströbel P, Trojan L, Steidler A, Fernández MI, Honeck P, Gabriel U, Weiss C, Grobholz R, Alken P, and Michel MS

European urology, 2008 Jul 30 - Who cited this? | PubMed ID: 18691807 | Fulltext

Prognostic implications of lymphangiogenesis in muscle-invasive transitional cell carcinoma of the bladder.

+ cite this

+ View Abstract

Fernández MI, Bolenz C, Trojan L, Steidler A, Weiss C, Alken P, Grobholz R, and Michel MS

European urology 53(3):571-80, 2008 Mar - Who cited this? | PubMed ID: 17804149 | Fulltext

Ureteroscopy for Stone Treatment Using New 270 degrees Semiflexible Endoscope: In Vitro, Ex Vivo, and Clinical Application.

+ cite this

+ View Abstract

Wendt-Nordahl G, Trojan L, Alken P, Michel MS, and Knoll T

Journal of endourology / Endourological Society 21(12):1439-44, 2007 Dec - Who cited this? | PubMed ID: 18186680 | Fulltext

[Complications and side effects of low dose rate brachytherapy for the treatment of prostate cancer: data on a 13 year follow-up study from Mannheim].

+ cite this

+ View Abstract

Trojan L, Harrer K, Schäfer J, Voss M, Welzel G, Bolenz C, Wenz F, Alken P, and Michel MS

Der Urologe. Ausg. A 46(11):1542-7, 2007 Nov - Who cited this? | PubMed ID: 17622506 | Fulltext

Newly developed mini-endoscope for diagnosis and follow-up of orthotopic bladder transitional-cell carcinoma in vivo.

+ cite this

+ View Abstract

Bolenz C, Wenzel M, Cao Y, Trojan L, Häcker A, Arancibia MF, Alken P, and Michel MS

Journal of endourology / Endourological Society 21(7):789-94, 2007 Jul - Who cited this? | PubMed ID: 17705773 | Fulltext

Complications in percutaneous nephrolithotomy.

+ cite this

+ View Abstract

Michel MS, Trojan L, and Rassweiler JJ

European urology 51(4):899-906; discussion 906, 2007 Apr - Who cited this? | PubMed ID: 17095141 | Fulltext

How important is research-based practice to chiropractors and massage therapists?.

+ cite this

+ View Abstract

Suter E, Vanderheyden LC, Trojan LS, Verhoef MJ, and Armitage GD

Journal of manipulative and physiological therapeutics 30(2):109-15, 2007 Feb - Who cited this? | PubMed ID: 17320731 | Fulltext

Correlation between motor function and lower urinary tract dysfunction in patients with infantile cerebral palsy.

+ cite this

+ View Abstract

Bross S, Honeck P, Kwon ST, Badawi JK, Trojan L, and Alken P

Neurourology and urodynamics 26(2):222-7, 2007 - Who cited this? | PubMed ID: 17009254 | Fulltext

Optimizing chemotherapy for transitional cell carcinoma by application of bcl-2 and bcl-xL antisense oligodeoxynucleotides.

+ cite this

+ View Abstract

Bolenz C, Becker A, Trojan L, Schaaf A, Cao Y, Weiss C, Alken P, and Michel MS

Urologic oncology 25(6):476-82, 2007 - Who cited this? | PubMed ID: 18047955 | Fulltext

The role of the lymphatic system and its specific growth factor, vascular endothelial growth factor C, for lymphogenic metastasis in prostate cancer.

+ cite this

+ View Abstract

Trojan L, Rensch F, Voss M, Grobholz R, Weiss C, Jackson DG, Alken P, and Michel MS

BJU international 98(4):903, 2006 Oct - Who cited this? | PubMed ID: 16978291 | Fulltext

Intravesical mitomycin C for superficial transitional cell carcinoma.

+ cite this

+ View Abstract

Bolenz C, Cao Y, Arancibia MF, Trojan L, Alken P, and Michel MS

Expert review of anticancer therapy 6(8):1273-82, 2006 Aug - Who cited this? | PubMed ID: 16925493 | Fulltext

IGF-II serum levels increase discrimination between benign prostatic hyperplasia and prostate cancer and improve the predictive value of PSA in clinical staging.

+ cite this

+ View Abstract

Trojan L, Bode C, Weiss C, Mayer D, Grobholz R, Alken P, and Michel MS

European urology 49(2):286-92; discussion 292, 2006 Feb - Who cited this? | PubMed ID: 16386354 | Fulltext

Intravenous contrast media in uroradiology: evaluation of safety and tolerability in almost 50,000 patients.

+ cite this

+ View Abstract

Wendt-Nordahl G, Rotert H, Trojan L, Michel MS, Peters CR, Alken P, and Knoll T

Medical principles and practice : international journal of the Kuwait University, Health Science Centre 15(5):358-61, 2006 - Who cited this? | PubMed ID: 16888393 | Fulltext

Up-regulation of insulin-like growth factor axis components in human primary prostate cancer correlates with tumor grade.

+ cite this

+ View Abstract

Liao Y, Abel U, Grobholz R, Hermani A, Trojan L, Angel P, and Mayer D

Human pathology 36(11):1186-96, 2005 Nov - Who cited this? | PubMed ID: 16260272 | Fulltext

[Relevance of the neuroendocrine differentiation in prostatic carcinoma].

+ cite this

+ View Abstract

Sauer CG, Trojan L, and Grobholz R

Der Pathologe 26(6):444-52, 2005 Nov - Who cited this? | PubMed ID: 16133158 | Fulltext

Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer.

+ cite this

+ View Abstract

Hermani A, Hess J, De Servi B, Medunjanin S, Grobholz R, Trojan L, Angel P, and Mayer D

Clinical cancer research : an official journal of the American Association for Cancer Research 11(14):5146-52, 2005 Jul 15 - Who cited this? | PubMed ID: 16033829 | Fulltext

Validation of computer-based training in ureterorenoscopy.

+ cite this

+ View Abstract

Knoll T, Trojan L, Haecker A, Alken P, and Michel MS

BJU international 95(9):1276-9, 2005 Jun - Who cited this? | PubMed ID: 15892816 | Fulltext

Influence of neuroendocrine tumor cells on proliferation in prostatic carcinoma.

+ cite this

+ View Abstract

Grobholz R, Griebe M, Sauer CG, Michel MS, Trojan L, and Bleyl U

Human pathology 36(5):562-70, 2005 May - Who cited this? | PubMed ID: 15948124 | Fulltext

[Current aspects of stone therapy].

+ cite this

+ View Abstract

Knoll T, Wendt-Nordahl G, Trojan L, Wenke A, Roeder N, and Alken P

Aktuelle Urologie 36(1):47-54, 2005 Feb - Who cited this? | PubMed ID: 15732004 | Fulltext

Identification of metastasis-associated genes in prostate cancer by genetic profiling of human prostate cancer cell lines.

+ cite this

+ View Abstract

Trojan L, Schaaf A, Steidler A, Haak M, Thalmann G, Knoll T, Gretz N, Alken P, and Michel MS

Anticancer research 25(1A):183-91, 2005 - Who cited this? | PubMed ID: 15816537 | Fulltext

Prostate cancer therapy: standard management, new options and experimental approaches.

+ cite this

+ View Abstract

Trojan L, Kiknavelidze K, Knoll T, Alken P, and Michel MS

Anticancer research 25(1B):551-61, 2005 - Who cited this? | PubMed ID: 15816628 | Fulltext

Simple models improve the discrimination of prostate cancers from the peripheral gland by T1-weighted dynamic MRI.

+ cite this

+ View Abstract

Kiessling F, Lichy M, Grobholz R, Heilmann M, Farhan N, Michel MS, Trojan L, Ederle J, Abel U, Kauczor HU, Semmler W, and Delorme S

European radiology 14(10):1793-801, 2004 Oct - Who cited this? | PubMed ID: 15232714 | Fulltext

Micelle delivery of doxorubicin increases cytotoxicity to prostate carcinoma cells.

+ cite this

+ View Abstract

McNealy TL, Trojan L, Knoll T, Alken P, and Michel MS

Urological research 32(4):255-60, 2004 Aug - Who cited this? | PubMed ID: 14714155 | Fulltext

The influence of oxalate on renal epithelial and interstitial cells.

+ cite this

+ View Abstract

Knoll T, Steidler A, Trojan L, Sagi S, Schaaf A, Yard B, Michel MS, and Alken P

Urological research 32(4):304-9, 2004 Aug - Who cited this? | PubMed ID: 15197515 | Fulltext

Lymph and blood vessel architecture in benign and malignant prostatic tissue: lack of lymphangiogenesis in prostate carcinoma assessed with novel lymphatic marker lymphatic vessel endothelial hyaluronan receptor (LYVE-1).

+ cite this

+ View Abstract

Trojan L, Michel MS, Rensch F, Jackson DG, Alken P, and Grobholz R

The Journal of urology 172(1):103-7, 2004 Jul - Who cited this? | PubMed ID: 15201747 | Fulltext

In vitro and ex vivo gene delivery into proximal tubular cells by means of laser energy--a potential approach for curing cystinuria?.

+ cite this

+ View Abstract

Knoll T, Sagi S, Trojan L, Schaaf A, Alken P, and Michel MS

Urological research 32(2):129-32, 2004 May - Who cited this? | PubMed ID: 14722697 | Fulltext

Expression of pro-angiogenic growth factors VEGF, EGF and bFGF and their topographical relation to neovascularisation in prostate cancer.

+ cite this

+ View Abstract

Trojan L, Thomas D, Knoll T, Grobholz R, Alken P, and Michel MS

Urological research 32(2):97-103, 2004 May - Who cited this? | PubMed ID: 15250102 | Fulltext

Cytotoxicity of cisplatin in bladder cancer is significantly enhanced by application of bcl-2 antisense oligonucleotides.

+ cite this

+ View Abstract

Schaaf A, Sagi S, Langbein S, Trojan L, Alken P, and Michel MS

Urologic oncology 22(3):188-92, 2004 - Who cited this? | PubMed ID: 15271313 | Fulltext

Expression of different vascular endothelial markers in prostate cancer and BPH tissue: an immunohistochemical and clinical evaluation.

+ cite this

+ View Abstract

Trojan L, Thomas D, Friedrich D, Grobholz R, Knoll T, Alken P, and Michel MS

Anticancer research 24(3a):1651-6, 2004 - Who cited this? | PubMed ID: 15274336 | Fulltext

Impact of holmium:YAG and neodymium:YAG lasers on the efficacy of DNA delivery in transitional cell carcinoma.

+ cite this

+ View Abstract

Knoll T, Trojan L, Langbein S, Sagi S, Alken P, and Michel MS

Lasers in medical science 19(1):33-6, 2004 - Who cited this? | PubMed ID: 15278722 | Fulltext

Acoustic energy: a new transfection method for cancer of the prostate, cancer of the bladder and benign kidney cells.

+ cite this

+ View Abstract

Michel MS, Erben P, Trojan L, Schaaf A, Kiknavelidze K, Knoll T, and Alken P

Anticancer research 24(4):2303-8, 2004 - Who cited this? | PubMed ID: 15330176 | Fulltext

Antisense strategy in malignant brain tumours treatment.

+ cite this

Trojan LA, Pan Y, Szpechcinski A, Ly A, Kopinski P, Chyczewski L, Kasprzak H, Donald A, and Trojan J

Roczniki Akademii Medycznej w Bialymstoku (1995) 49 Suppl 1:94-7, 2004 - Who cited this? | PubMed ID: 15638387 | Fulltext

Presence of MHC-I in rat glioma cells expressing antisense IGF-I-receptor RNA.

+ cite this

+ View Abstract

Szpechcinski A, Trzos R, Jarocki P, Trojan LA, Oficjalska K, Junkiert A, Wei MX, Mazurek M, Czapiewska JL, Niklinski J, Kopiński P, Chyczewski L, Kasacka I, and Trojan J

Roczniki Akademii Medycznej w Bialymstoku (1995) 49 Suppl 1:98-104, 2004 - Who cited this? | PubMed ID: 15638388 | Fulltext

Increase of AKT/PKB expression correlates with gleason pattern in human prostate cancer.

+ cite this

+ View Abstract

Liao Y, Grobholz R, Abel U, Trojan L, Michel MS, Angel P, and Mayer D

International journal of cancer. Journal international du cancer 107(4):676-80, 2003 Nov 20 - Who cited this? | PubMed ID: 14520710 | Fulltext

Search Google Scholar for Trojan L

Join Labmeeting

Organize and search your PDF collection
Collect papers
Search millions of papers
Keep up to date with paper alerts
Read your papers from anywhere
Recommend papers to colleagues
Manage your lab

Labmeeting is a web service for researchers. Sign up with your academic email address.

Individuals or corporations not affiliated with an academic institution can request a trial subscription.

Got a question?
The Labmeeting Network
has the answer.
Ask scientists at top universities like Harvard, Stanford, and MIT for their expert opinion!